Quantcast

Latest Gastroenterology Stories

2014-09-29 08:32:42

MILFORD, Pa., Sept. 29, 2014 /PRNewswire/ -- Manzo Pharmaceuticals, Inc. (OTCPink:FOGCD), today announced at the three month mark in a six month animal study, that the results of the lactase producing probiotic, Lacto-Freedom(TM), has been very successful. This successful testing brings Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials. The 6-month study is being conducted by Celprogen,Inc. using laboratory rats to test the new probiotic...

2014-09-25 08:27:15

SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Meritage Pharma, Inc. announced today positive Phase 2b results of oral budesonide suspension (OBS) for the treatment of adolescents and adults with eosinophilic esophagitis (EoE), a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. OBS achieved the co-primary endpoints of reduction in inflammation (p< 0.0001) and symptom of dysphagia (p=0.0096) with statistical...

2014-09-24 23:02:01

The Firm is evaluating Byetta lawsuits and other product liability claims that allege incretin mimetic diabetes drugs caused patients to develop pancreatic cancer, pancreatitis and thyroid cancer. New York, New York (PRWEB) September 24, 2014 Byetta lawsuits(http://www.byettalawsuit.com) and other product liability claims that allege incretin mimetic Type 2 diabetes medications caused patients to develop pancreatic cancer continue to move forward in U.S. courts, Bernstein Liebhard LLP...

2014-09-23 08:30:41

Inaugural Product Donation Supports Global Health Community in Fight Against Ebola; Joins Clinton Global Initiative SAN FRANCISCO, Sept. 23, 2014 /PRNewswire/ -- Today, DripDrop, the first great tasting oral rehydration solution (ORS), announced the formation of the DripDrop Foundation, with its primary mission to alleviate suffering due to preventable dehydration worldwide. Utilizing scientific advancements in Oral Rehydration Therapy (ORT), the foundation aims to introduce...

2014-09-23 04:21:56

OxThera AB announced today that its product Oxabact® has been granted an Orphan Drug Designation in the European Union for treatment of Short Bowel Syndrome (SBS) STOCKHOLM, September 23, 2014 /PRNewswire/ -- SBS is a highly disabling malabsorptive condition. SBS is associated with significant morbidity and mortality, reduced quality of life and high healthcare costs. "We are happy to announce that Oxabact(R) is now also recognized as a potential treatment for Short...

2014-09-18 20:22:43

- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept. 18, 2014 /PRNewswire/ -- Trulicity(TM) (dulaglutide), approved today by the U.S. Food and Drug Administration, is the latest Eli Lilly and Company (NYSE: LLY) treatment option for adults with type 2 diabetes. Trulicity is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2...

2014-09-18 12:30:08

BETHESDA, Md., Sept. 18, 2014 /PRNewswire-USNewswire/ -- Physician members of the American Gastroenterological Association (AGA) will travel to Capitol Hill tomorrow to send a clear message to Congress that impending changes in health care will jeopardize both the science and practice of gastroenterology. The inability of Congress to address key issues of concern to our members will directly affect our ability to care for Americans with digestive disorders. Gastroenterologists...

2014-09-18 04:21:05

Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). Dr. Daniel Teper, Chairman and CEO of Immune comments: "Bertilimumab is...

2014-09-11 23:01:20

The Firm is evaluating Byetta lawsuits on behalf of individuals who developed pancreatitis, pancreatic cancer or thyroid cancer allegedly due to their use of Byetta or other incretin mimetic Type 2 diabetes drug. New York (PRWEB) September 11, 2014 Byetta lawsuits (http://www.byettalawsuit.com) and legal claims involving other incretin mimetic Type 2 diabetes drugs, including Januvia and Victoza, continue to move forward in a federal multidistrict litigation now underway in U.S. District...

2014-09-10 12:29:04

-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board -- ROCKVILLE, Md., Sept. 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that its Investor Day to highlight...


Latest Gastroenterology Reference Libraries

Duodenal Atresia
2013-07-19 15:38:56

Duodenal atresia is a congenital closure of the lumen of the duodenum, which is the first portion of the small intestine and is separated from the stomach by the pyloric sphincter. During fetal development, the duodenum develops from the posterior portion of the foregut and the anterior portion of the midgut. The liver and pancreas originate from the diverticulum arising from the ventral part of the duodenum, and the bile duct runs along the ventral free side of the duodenum. Rotation and...

Small Intestine
2013-03-04 15:13:09

The small intestine is the part of the digestive tract that follows the stomach and is followed by the large intestine. Formation and Orientation The small intestine is on average between 22 feet 6 inches and 24 feet 4 inches. It is composed of three distinct structural parts; the duodenum, the jejunum, and the ileum. The duodenum is the part of the intestine where most chemical breakdown happens; it is also the shortest part of the intestine. It starts at the duodenal bulb and stops...

Stomach
2013-03-04 14:34:35

The stomach is the hollow organ that helps along digestion after mastication (chewing). It is the next step after the esophagus and before the small intestines. Formation and Orientation The stomach is composed of four parts. The cardia is the first part of the stomach in the digestive tract. It is the part of the stomach that allows the food to empty from the esophagus. The most northern part of the stomach is the Fundus. This section is the part that creates the curved part of the...

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

Esophagus
2012-07-01 19:23:24

The Esophagus is an organ which consists of a muscular tube through which food passes from the pharynx to the stomach. During swallowing, food passes from the mouth through the pharynx into the esophagus and travels to the stomach via peristalsis -- a radially symmetrical contraction and relaxation of muscles that propagate in a wave downward. The word esophagus is derived from the Greek word oisophagos, meaning “entrance for eating.” In humans the esophagus is continuous with the...

More Articles (11 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related